RxDoctor Payments Data

Sierra Presley, APRN

Family · Mount Vernon, OHNPI 1194399790

Payments from drug & device makers

$1,276in general payments, 2019–2025

Across 63 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$316
  • Corcept Therapeutics$205
  • AbbVie$127
  • Pfizer$126
  • Lilly USA, LLC$68
  • Dexcom, Inc.$68
  • plus $365 from 12 others

What the payments were for

  • Food & beverage$1,276100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,276 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$26,922
Medicare patients
152
Services billed
391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban48$34,502
OzempicSemaglutide20$25,849
XareltoRivaroxaban13$18,477
FarxigaDapagliflozin Propanediol13$11,007
LinzessLinaclotide17$10,920
Tresiba Flextouch U-100Insulin Degludec11$5,220
SymbicortBudesonide/Formoterol Fumarate12$4,160
Levothyroxine Sodium140$1,988
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$1,955
Albuterol Sulfate HfaAlbuterol Sulfate54$1,137
Atorvastatin Calcium104$1,093
Potassium Chloride67$1,069
Omeprazole116$990
Duloxetine Hcl39$901
Rosuvastatin Calcium79$832

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$126$34,50248 claims
Novo NordiskOzempic$49$25,84920 claims
AstraZenecaFarxiga, Symbicort$60$15,16625 claims
AbbVieLinzess$127$10,92017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Mount Vernon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →